1. Prospective pharmacological potential of cryptotanshinone in cancer therapy
   Ashif Ahamed et al, 2023, Pharmacological Research - Modern Chinese Medicine CrossRef
2. Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma
   Jéssica Mariane Ferreira Mendes et al, 2020, International Journal of Molecular Sciences CrossRef
3. Therapeutic Potential of Natural Products in Lung Cancer
   Qi-Xing Yan et al, 2021, International Journal of Pharmacology CrossRef
4. Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma
   Jinman Zhuang et al, 2022, Respiratory Research CrossRef
5. Analysis of the expression and mechanism of follistatin‑like protein 1 in cervical cancer
   Zhen Liu et al, 2023, Oncology Reports CrossRef
6. Systems Medicine Design based on Systems Biology Approaches and Deep Neural Network for Gastric Cancer
   Shan-Ju Yeh et al, 2022, IEEE/ACM Transactions on Computational Biology and Bioinformatics CrossRef
7. Phytochemicals in cancer and their effect on the PI3K/AKT-mediated cellular signalling
   Olaf-Georg Issinger et al, 2021, Biomedicine & Pharmacotherapy CrossRef
8. Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
   Magdalena Rausch et al, 2021, Cancers CrossRef
9. A Comparison between Bulgarian Tanacetum parthenium Essential Oil from Two Different Locations
   Borislava Lechkova et al, 2024, Molecules CrossRef
10. Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents
    Xingchen LIU et al, 2022, Chinese Journal of Natural Medicines CrossRef
11. Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway
    Liru Huang et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef
12. Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention
    Israa A. Cheikh et al, 2022, Expert Opinion on Drug Discovery CrossRef
13. Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer
    Liyan Yang et al, 2021, Biomedicines CrossRef
14. Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
    Joana Jorge et al, 2023, International Journal of Molecular Sciences CrossRef
15. The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
    Tao An et al, 2022, Drug Design, Development and Therapy CrossRef
16. Signature based on RNA-binding protein-related genes for predicting prognosis and guiding therapy in non-small cell lung cancer
    Ti-Wei Miao et al, 2022, Frontiers in Genetics CrossRef
17. The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm
    Sipin Zhu et al, 2023, Frontiers in Pharmacology CrossRef
18. Chemotherapeutics
    Yuri N. Clement, 2024, Pharmacognosy CrossRef
19. Plants as a Source of Anticancer Agents: From Bench to Bedside
    Wamidh H. Talib et al, 2022, Molecules CrossRef
20. Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight
    Rutuja Damare et al, 2024, Phytotherapy Research CrossRef
21. Downregulation of miR‐100‐5p in cancer‐associated fibroblast‐derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma
    Chao Chen et al, 2023, Cancer Medicine CrossRef